Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Neha Dhiman, Jayrajsinh Sarvaiya & Poorti Mohindroo. (2022) A drift on liposomes to proliposomes: recent advances and promising approaches. Journal of Liposome Research 32:4, pages 317-331.
Read now
Read now
Tulshidas S. Patil, Ashwini S. Deshpande, Shirish Deshpande & Pravin Shende. (2019) Targeting pulmonary tuberculosis using nanocarrier-based dry powder inhalation: current status and futuristic need. Journal of Drug Targeting 27:1, pages 12-27.
Read now
Read now
Piyush Mehta, C. Bothiraja, Shivajirao Kadam & Atmaram Pawar. (2018) Potential of dry powder inhalers for tuberculosis therapy: facts, fidelity and future. Artificial Cells, Nanomedicine, and Biotechnology 46:sup3, pages S791-S806.
Read now
Read now
Jagdeep Singh, Tarun Garg, Goutam Rath & Amit K. Goyal. (2016) Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis – a critical review. Drug Delivery 23:5, pages 1676-1698.
Read now
Read now
Bin Zheng, Shuang Yang, Chunyu Fan, Ye Bi, Lin Du, Lingzhi Zhao, Robert J. Lee, Lesheng Teng, Lirong Teng & Jing Xie. (2016) Oleic acid derivative of polyethylenimine-functionalized proliposomes for enhancing oral bioavailability of extract of Ginkgo biloba. Drug Delivery 23:4, pages 1194-1203.
Read now
Read now
Kanogwan Kaewjan & Teerapol Srichana. (2016) Nano spray-dried pyrazinamide-l-leucine dry powders, physical properties and feasibility used as dry powder aerosols. Pharmaceutical Development and Technology 21:1, pages 68-75.
Read now
Read now
Ninell P. Mortensen, Phillip Durham & Anthony J. Hickey. (2014) The role of particle physico-chemical properties in pulmonary drug delivery for tuberculosis therapy. Journal of Microencapsulation 31:8, pages 785-795.
Read now
Read now
Articles from other publishers (47)
Shaveta Ahalwat, Dinesh Chandra Bhatt, Surbhi Rohilla, Vikas Jogpal, Kirti Sharma, Tarun Virmani, Girish Kumar, Abdulsalam Alhalmi, Ali S. Alqahtani, Omar M. Noman & Marwan Almoiliqy. (2023) Mannose-Functionalized Isoniazid-Loaded Nanostructured Lipid Carriers for Pulmonary Delivery: In Vitro Prospects and In Vivo Therapeutic Efficacy Assessment. Pharmaceuticals 16:8, pages 1108.
Crossref
Crossref
Teerapol Srichana, Ekawat Thawithong, Titpawan Nakpheng & Pijush Kumar Paul. (2023) Flow cytometric analysis, confocal laser scanning microscopic, and holotomographic imaging demonstrate potentials of levofloxacin dry powder aerosols for TB treatment. Journal of Drug Delivery Science and Technology 84, pages 104464.
Crossref
Crossref
Thomas Manning, Jenu Thomas-Richardson, Courtney Johnson, Krupesh Patel, Yatri Thaker, Govind Thomas-Richardson, Dennis Philips & Greg Wylie. 2023. Tuberculosis. Tuberculosis
305
320
.
Maharshi Thalla, Gangipangi Vijayakumar, Sudhagar Selvaraju & Subham Banerjee. (2022) Pharmacoengineered Lipid Core–Shell Nanoarchitectonics to Influence Human Alveolar Macrophages Uptake for Drug Targeting Against Tuberculosis. Journal of Inorganic and Organometallic Polymers and Materials 32:9, pages 3276-3291.
Crossref
Crossref
Nidhi Nainwal, Yuwanshi Sharma & Vikash Jakhmola. (2022) Dry powder inhalers of antitubercular drugs. Tuberculosis 135, pages 102228.
Crossref
Crossref
Anežka Nováková, Martin Šíma & Ondřej Slanař. (2022) Factors Affecting Drug Exposure after Inhalation. Prague Medical Report 123:3, pages 129-139.
Crossref
Crossref
Pooja Sanjay Khairnar, Ajit Singh & Rahul Shukla. 2022. Nanotechnology for Infectious Diseases. Nanotechnology for Infectious Diseases
387
417
.
Yinghan Chan, Sin Wi Ng & Laura Soon. 2022. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases
375
433
.
Amarjitsing Rajput, Satish Mandlik & Varsha Pokharkar. (2021) Nanocarrier-Based Approaches for the Efficient Delivery of Anti-Tubercular Drugs and Vaccines for Management of Tuberculosis. Frontiers in Pharmacology 12.
Crossref
Crossref
Jayoung Chae, Yonghyun Choi, Masayoshi Tanaka & Jonghoon Choi. (2021) Inhalable nanoparticles delivery targeting alveolar macrophages for the treatment of pulmonary tuberculosis. Journal of Bioscience and Bioengineering 132:6, pages 543-551.
Crossref
Crossref
Nisa Laohapojanart, Chaveewan Ratanajamit, Kamon Kawkitinarong & Teerapol Srichana. (2021) Efficacy and safety of combined isoniazid-rifampicin-pyrazinamide-levofloxacin dry powder inhaler in treatment of pulmonary tuberculosis: A randomized controlled trial. Pulmonary Pharmacology & Therapeutics 70, pages 102056.
Crossref
Crossref
Madushani H. Dahanayake & Anil C.A. Jayasundera. (2021) Nano-based drug delivery optimization for tuberculosis treatment: A review. Journal of Microbiological Methods 181, pages 106127.
Crossref
Crossref
Kapil Sharma. 2021. A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy. A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy
281
306
.
Zhi Ming Tan, Gui Ping Lai, Manisha Pandey, Teerapol Srichana, Mallikarjuna Rao Pichika, Bapi Gorain, Subrat Kumar Bhattamishra & Hira Choudhury. (2020) Novel Approaches for the Treatment of Pulmonary Tuberculosis. Pharmaceutics 12:12, pages 1196.
Crossref
Crossref
Jana K. Alwattar, Racha Chouaib, Alia Khalil & Mohammed M. Mehanna. (2020) A novel multifaceted approach for wound healing: Optimization and in vivo evaluation of spray dried tadalafil loaded pro-nanoliposomal powder. International Journal of Pharmaceutics 587, pages 119647.
Crossref
Crossref
Zerrin SEZGİN BAYINDIR & Nadir DERELİ. (2020) RECENT DEVELOPMENTS ON PROLIPOSOME TECHNOLOGY AND APPLICATIONS. Ankara Universitesi Eczacilik Fakultesi Dergisi, pages 308-333.
Crossref
Crossref
Mohamed Rahamathulla, Gangadharappa H.V, Gangadhar Veerapu, Umme Hani, Yahya Alhamhoom, Ali Alqahtani & Afrasim Moin. (2020) Characterization, Optimization, In Vitro and In Vivo Evaluation of Simvastatin Proliposomes, as a Drug Delivery. AAPS PharmSciTech 21:4.
Crossref
Crossref
Piyush P. Mehta, Debjit Ghoshal, Atmaram P. Pawar, Shivajirao S. Kadam & Vividha S. Dhapte-Pawar. (2020) Recent advances in inhalable liposomes for treatment of pulmonary diseases: Concept to clinical stance. Journal of Drug Delivery Science and Technology 56, pages 101509.
Crossref
Crossref
Ahmed Gardouh, Sherif Shaker, Zainab Z. Ali & Mamdouh Ghorab. (2020) Silymarin Spray-Dried Proliposomes: Preparation, Characterization and Cytotoxic Evaluation. Drug Delivery Letters 10:1, pages 14-23.
Crossref
Crossref
Damián Eduardo Pérez-Martínez & Roberto Zenteno-Cuevas. 2020. Nanotechnology Based Approaches for Tuberculosis Treatment. Nanotechnology Based Approaches for Tuberculosis Treatment
37
52
.
Caleb F. Anderson, Maria E. Grimmett, Christopher J. Domalewski & Honggang Cui. (2019) Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases. WIREs Nanomedicine and Nanobiotechnology 12:1.
Crossref
Crossref
Ngoc Thuy Trang Le, Van Du Cao, Thi Nhu Quynh Nguyen, Thi Thu Hong Le, Thach Thao Tran & Thai Thanh Hoang Thi. (2019) Soy Lecithin-Derived Liposomal Delivery Systems: Surface Modification and Current Applications. International Journal of Molecular Sciences 20:19, pages 4706.
Crossref
Crossref
Tiantian Ye, Siping Sun, Tiffanie Daisy Sugianto, Patricia Tang, Thaigarajan Parumasivam, Yoon Kyung Chang, Ariel Astudillo, Shujun Wang & Hak-Kim Chan. (2018) Novel combination proliposomes containing tobramycin and clarithromycin effective against Pseudomonas aeruginosa biofilms. International Journal of Pharmaceutics 552:1-2, pages 130-138.
Crossref
Crossref
Mohammad A.M. Momin, Ian G. Tucker & Shyamal C. Das. (2018) High dose dry powder inhalers to overcome the challenges of tuberculosis treatment. International Journal of Pharmaceutics 550:1-2, pages 398-417.
Crossref
Crossref
Tulshidas S. Patil & Ashwini S. Deshpande. (2018) Nanostructured lipid carriers-based drug delivery for treating various lung diseases: A State‐of‐the‐Art Review. International Journal of Pharmaceutics 547:1-2, pages 209-225.
Crossref
Crossref
Huner K. Omer, Nozad R. Hussein, Amina Ferraz, Mohammad Najlah, Waqar Ahmed, Kevin M. G. Taylor & Abdelbary M. A. Elhissi. (2018) Spray-Dried Proliposome Microparticles for High-Performance Aerosol Delivery Using a Monodose Powder Inhaler. AAPS PharmSciTech 19:5, pages 2434-2448.
Crossref
Crossref
Roberto Nisini, Noemi Poerio, Sabrina Mariotti, Federica De Santis & Maurizio Fraziano. (2018) The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases. Frontiers in Immunology 9.
Crossref
Crossref
Rajesh Jain, Hemali Savla, Isha Naik, Jinesh Maniar, Kapil Punjabi, Shashikant Vaidya & Mala Menon. 2018. Handbook of Nanomaterials for Industrial Applications. Handbook of Nanomaterials for Industrial Applications
587
620
.
Daniela Traini & Paul M Young. (2017) Drug delivery for tuberculosis: is inhaled therapy the key to success?. Therapeutic Delivery 8:10, pages 819-821.
Crossref
Crossref
Qing Lin, Guijin Liu, Ziyi Zhao, Dongwei Wei, Jiafeng Pang & Yanbin Jiang. (2017) Design of gefitinib-loaded poly (l-lactic acid) microspheres via a supercritical anti-solvent process for dry powder inhalation. International Journal of Pharmaceutics 532:1, pages 573-580.
Crossref
Crossref
Kamal Dua, Nicole G. Hansbro, Paul S. Foster & Philip M. Hansbro. (2016) MicroRNAs as therapeutics for future drug delivery systems in treatment of lung diseases. Drug Delivery and Translational Research 7:1, pages 168-178.
Crossref
Crossref
Tiantian Ye, Jiaqi Yu, Qiuhua Luo, Shujun Wang & Hak-Kim Chan. (2017) Inhalable clarithromycin liposomal dry powders using ultrasonic spray freeze drying. Powder Technology 305, pages 63-70.
Crossref
Crossref
Lalit Kumar, Shivani Verma, Bhuvaneshwar Vaidya & Neelesh K. Mehra. 2017. Nanostructures for Antimicrobial Therapy. Nanostructures for Antimicrobial Therapy
293
324
.
Jennifer Wong, Maurizio Ricci & Hak-Kim Chan. 2016. Drug Delivery Systems for Tuberculosis Prevention and Treatment. Drug Delivery Systems for Tuberculosis Prevention and Treatment
161
196
.
Sanketkumar Pandya, Anuradha Gupta, Rajeev Ranjan, Madhur Sachan, Atul Kumar Agrawal & Amit Misra. 2016. Drug Delivery Systems for Tuberculosis Prevention and Treatment. Drug Delivery Systems for Tuberculosis Prevention and Treatment
213
238
.
A.J. Hickey, P.G. Durham, A. Dharmadhikari & E.A. Nardell. (2016) Inhaled drug treatment for tuberculosis: Past progress and future prospects. Journal of Controlled Release 240, pages 127-134.
Crossref
Crossref
Kajiram Adhikari, Wilaiporn Buatong, Ekawat Thawithong, Tan Suwandecha & Teerapol Srichana. (2015) Factors Affecting Enhanced Permeation of Amphotericin B Across Cell Membranes and Safety of Formulation. AAPS PharmSciTech 17:4, pages 820-828.
Crossref
Crossref
Thaigarajan Parumasivam, Rachel Yoon Kyung Chang, Sharif Abdelghany, Tian Tian Ye, Warwick John Britton & Hak-Kim Chan. (2016) Dry powder inhalable formulations for anti-tubercular therapy. Advanced Drug Delivery Reviews 102, pages 83-101.
Crossref
Crossref
Gemma O'Connor, Laura E. Gleeson, Aidan Fagan-Murphy, Sally-Ann Cryan, Mary P. O'Sullivan & Joseph Keane. (2016) Sharpening nature's tools for efficient tuberculosis control: A review of the potential role and development of host-directed therapies and strategies for targeted respiratory delivery. Advanced Drug Delivery Reviews 102, pages 33-54.
Crossref
Crossref
Teerapol Srichana, Chaveewan Ratanajamit, Siwasak Juthong, Tan Suwandecha, Nisa Laohapojanart, Petchawan Pungrassami & Alwar Ramanujam Padmavathi. (2016) Evaluation of Proinflammatory Cytokines and Adverse Events in Healthy Volunteers upon Inhalation of Antituberculosis Drugs. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 39:11, pages 1815-1822.
Crossref
Crossref
Bhushan S. Pattni, Vladimir V. Chupin & Vladimir P. Torchilin. (2015) New Developments in Liposomal Drug Delivery. Chemical Reviews 115:19, pages 10938-10966.
Crossref
Crossref
Marius Hittinger, Jenny Juntke, Stephanie Kletting, Nicole Schneider-Daum, Cristiane de Souza Carvalho & Claus-Michael Lehr. (2015) Preclinical safety and efficacy models for pulmonary drug delivery of antimicrobials with focus on in vitro models. Advanced Drug Delivery Reviews 85, pages 44-56.
Crossref
Crossref
Ioana Diana Olaru, Florian von Groote-Bidlingmaier, Jan Heyckendorf, Wing Wai Yew, Christoph Lange & Kwok Chiu Chang. (2015) Novel drugs against tuberculosis: a clinician's perspective. European Respiratory Journal 45:4, pages 1119-1131.
Crossref
Crossref
Dinh-Duy Pham, Elias Fattal & Nicolas Tsapis. (2015) Pulmonary drug delivery systems for tuberculosis treatment. International Journal of Pharmaceutics 478:2, pages 517-529.
Crossref
Crossref
Mohammed M. Mehanna, Salma M. Mohyeldin & Nazik A. Elgindy. (2014) Respirable nanocarriers as a promising strategy for antitubercular drug delivery. Journal of Controlled Release 187, pages 183-197.
Crossref
Crossref
Eleonora Maretti, Tiziana Rossi, Moreno Bondi, Maria Antonietta Croce, Miriam Hanuskova, Eliana Leo, Francesca Sacchetti & Valentina Iannuccelli. (2014) Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis. International Journal of Pharmaceutics 462:1-2, pages 74-82.
Crossref
Crossref
M. Hoppentocht, P. Hagedoorn, H.W. Frijlink & A.H. de Boer. (2014) Developments and strategies for inhaled antibiotic drugs in tuberculosis therapy: A critical evaluation. European Journal of Pharmaceutics and Biopharmaceutics 86:1, pages 23-30.
Crossref
Crossref